Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,150 shares at $157.56 ($1.6M) on 2017-07-21, disclosed to the SEC on 2017-07-21.
Open-market sale of $1.6M VRTX by EVP, CFO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.56 | 400 | $63K | 3.9% |
| 2 | $158.62 | 1,829 | $290K | 17.8% |
| 3 | $159.61 | 815 | $130K | 8.0% |
| 4 | $161.01 | 2,000 | $322K | 19.7% |
| 5 | $161.71 | 5,106 | $826K | 50.6% |
| Total | $160.68 avg | 10,150 |
| $1.6M |
| 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |
| ACOR | SELL | 2018-05-04 | $237K | — | Filing → |